Genetic Diversity, Natural Acquired Antibody and Recombinant Vaccine Is Critical in Vaccine Malaria Disease

Journal of Parasitic Diseases: Diagnosis and Therapy
doi 10.4066/2591-7846.1000029
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Recombinant Virus Vaccine for Bluetongue Disease in Sheep.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1990English

Malaria Vaccine Development.

Clinical Microbiology Reviews
ImmunologyEnvironmentalPublic HealthMicrobiologyMicrobiology EpidemiologyInfectious DiseasesOccupational Health
1994English

PATH Malaria Vaccine Initiative (MVI): Perspectives on the Status of Malaria Vaccine Development

Human Vaccines
2010English

Genetic Diversity of the Malaria Vaccine Candidate Plasmodium Falciparum Merozoite Surface Protein-3 in a Hypoendemic Transmission Environment

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2009English

A Combined Analysis of Immunogenicity, Antibody Kinetics and Vaccine Efficacy From Phase 2 Trials of the RTS,S Malaria Vaccine

BMC Medicine
Medicine
2014English

Evaluation of Specific Antibody Responses to Selected Malaria Vaccine Candidates in Zimbabwean Children

Clinical Nursing Studies
2015English

Impact of Host Genetic Polymorphisms on Vaccine Induced Antibody Response

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2016English

Policy Challenges in Malaria Vaccine Introduction

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2004English

New Malaria Vaccine Shows Promise

BMJ
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy